News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
Longitude Capital Partners II, LLC
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/18/2023 |
SC 13D/A
| Longitude Capital Partners II, LLC reports a 5% stake in RXSIGHT, INC. |
| 06/05/2023 |
SC 13D/A
| Longitude Capital Partners II, LLC reports a 7.5% stake in RXSIGHT, INC. |
| 03/16/2023 |
SC 13D/A
| Longitude Capital Partners II, LLC reports a 0.3% stake in APTINYX INC. |
| 01/03/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 02/14/2022 |
SC 13G
| Longitude Capital Partners II, LLC reports a 12.2% stake in Rapid Micro Biosystems, Inc. |
| 08/13/2021 |
SC 13D
| Longitude Capital Partners II, LLC reports a 9.1% stake in RXSIGHT, INC. |
| 07/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/14/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/12/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 06/11/2020 |
3
| Longitude Capital Partners II, LLC (10% Owner) has filed a Form 3 on Vaxcyte, Inc. |
| 03/23/2020 |
SC 13D/A
| Longitude Capital Partners II, LLC reports a 10% stake in KALA PHARMACEUTICALS, INC. |
| 02/12/2020 |
SC 13D/A
| Longitude Capital Partners II, LLC reports a 7.7% stake in APTINYX INC. |
| 02/12/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/12/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 11/18/2019 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 11/07/2019 |
3
| Longitude Capital Partners II, LLC (10% Owner) has filed a Form 3 on Venus Concept Inc. |
| 02/12/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 10/12/2018 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 08/07/2018 |
SC 13G
| Longitude Capital Partners II, LLC reports a 6% stake in Nabriva Therapeutics plc |
| 07/06/2018 |
SC 13D
| Longitude Capital Partners II, LLC reports a 7.2% stake in TRICIDA, INC. |
| 07/02/2018 |
4
| Longitude Capital Partners II, LLC (10% Owner) has filed a Form 4 on Tricida, Inc.|
Txns:
| Converted 2,431,511 shares
@ $0
Converted 456,644 shares
@ $0
Bought 131,579 shares
@ $19, valued at
$2.5M
Converted 9,677,419 convertible preferred
@ $0
Converted 1,817,447 convertible preferred
@ $0 |
|
| 07/02/2018 |
SC 13D
| Longitude Capital Partners II, LLC reports a 9.5% stake in APTINYX INC. |
| 06/27/2018 |
3
| Longitude Capital Partners II, LLC (10% Owner) has filed a Form 3 on Tricida, Inc. |
| 06/26/2018 |
4
| Longitude Capital Partners II, LLC (10% Owner) has filed a Form 4 on Aptinyx Inc.|
Txns:
| Converted 1,047,450 shares
@ $0
Converted 1,197,076 shares
@ $0
Converted 795,553 shares
@ $0
Bought 150,000 shares
@ $16, valued at
$2.4M
Converted 28,895,188 convertible preferred
@ $0
Converted 33,022,786 convertible preferred
@ $0
Converted 21,946,301 convertible preferred
@ $0 |
|
| 06/20/2018 |
3
| Longitude Capital Partners II, LLC (10% Owner) has filed a Form 3 on Aptinyx Inc. |
| 02/12/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/12/2018 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 07/27/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/19/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/21/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/10/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend] |
| 12/01/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/31/2016 |
4
| Longitude Capital Partners II, LLC (10% Owner) has filed a Form 4 on Aimmune Therapeutics, Inc.|
Txns:
| Bought 33,064 shares
@ $13.4986, valued at
$446.3k
Bought 45,440 shares
@ $14.1465, valued at
$642.8k
|
|
|
|